Korenberg Matthew E Insider Trades

Insider Trading History

Track insider trading activity for Korenberg Matthew E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Palvella Therapeutics
Palvella Therapeutics PVLA
Cfo, Treasurer
Holding Value $150k 1,000 shares
Last Trade
Jun 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$109k 1,000 shares
$108.81
$149.68
Palvella Therapeutics
Palvella Therapeutics PVLA
Cfo, Treasurer
Holding Value $24.9M 166,100 shares
Last Trade
Jun 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$109k 1,000 shares
$108.81
$149.68
Lifecore Biomedical
Lifecore Biomedical LFCR
Director
Holding Value $323k 69,967 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 25,907 shares
$5.79
$4.61
Palvella Therapeutics
Palvella Therapeutics PVLA
Cfo, Treasurer
Holding Value $6.6M 44,123 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.37M 44,123 shares
$76.43
$149.68
Lifecore Biomedical
Lifecore Biomedical LFCR
Director
Holding Value $203k 44,060 shares
Last Trade
Jul 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 19,506 shares
$7.69
$4.61
Palvella Therapeutics
Palvella Therapeutics PVLA
CFO And Treasurer
Holding Value $18.5M 123,559 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$149.68
Palvella Therapeutics
Palvella Therapeutics PVLA
Cfo, Treasurer
Holding Value $25M 167,100 shares
Last Trade
Dec 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$149.68
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $18.2M 60,549 shares
Last Trade
Sep 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$974k 9,772 shares
$99.66
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $17.5M 58,068 shares
Last Trade
Sep 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$989k 9,772 shares
$101.22
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $12.8M 42,436 shares
Last Trade
Sep 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$974k 9,772 shares
$99.66
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $17.2M 57,052 shares
Last Trade
Sep 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$512k 4,982 shares
$102.80
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $119k 395 shares
Last Trade
Sep 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$512k 4,982 shares
$102.80
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $15.3M 50,777 shares
Last Trade
Sep 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$653k 6,275 shares
$104.10
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $15.7M 52,070 shares
Last Trade
Sep 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$337k 3,214 shares
$105.00
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $16.3M 54,008 shares
Last Trade
Sep 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$606k 5,774 shares
$105.00
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $7.81M 25,949 shares
Last Trade
Sep 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$606k 5,774 shares
$105.00
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $16.5M 54,722 shares
Last Trade
Aug 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.2M 11,389 shares
$105.61
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $19.6M 65,174 shares
Last Trade
Aug 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$661k 6,312 shares
$104.79
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
President & COO
Holding Value $20.2M 67,211 shares
Last Trade
Aug 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$122k 1,157 shares
$105.54
$300.97
Lifecore Biomedical
Lifecore Biomedical LFCR
Director
Holding Value $113k 24,554 shares
Last Trade
Aug 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 24,554 shares
$5.60
$4.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up